Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Oncologist. 2013;18(3):336-44. doi: 10.1634/theoncologist.2012-0299. Epub 2013 Feb 21.
Many patients with head and neck cancer (HNC) experience depressive symptoms after treatment. This randomized controlled trial investigated the effects of a psychosocial nurse counseling and after intervention (NUCAI) versus usual care on the depressive and HNC-related physical symptoms of patients with HNC at 1 year after diagnosis.
A total of 205 patients with HNC were randomly assigned to either intervention (n = 103) or usual care (n = 102), with stratification for gender and tumor stage. The NUCAI, which consisted of six bimonthly 45-minute counseling sessions, was a problem-focused intervention aimed at helping patients to manage the physical, psychological, and social consequences of HNC and its treatment. It was nurse-led and offered in combination with regular medical follow-up visits at the University Medical Center Utrecht, the Netherlands. Depressive symptoms at 1 year after diagnosis were the primary outcome. Analyses were performed on an intention-to-treat basis for the total sample and for a predefined subgroup of patients with raised levels of depressive symptoms (Center for Epidemiologic Studies-Depression score ≥ 12; n = 91) at baseline using mixed-effect models.
One year after HNC treatment, levels of depressive symptoms were significantly lower in the intervention group than in the control group in the total sample and in the subgroup of patients with raised levels of depressive symptoms.
The NUCAI was feasible and effective in reducing depressive symptoms in patients with HNC 1 year after HNC treatment, and especially in patients with raised levels of depressive symptoms. The results of this study need to be confirmed in future studies before the NUCAI can be used in daily clinical practice.
许多头颈部癌症(HNC)患者在治疗后会出现抑郁症状。这项随机对照试验旨在研究心理社会护士咨询和干预后(NUCAI)与常规护理对诊断后 1 年 HNC 患者的抑郁和 HNC 相关身体症状的影响。
共有 205 名 HNC 患者被随机分配到干预组(n = 103)或常规护理组(n = 102),按性别和肿瘤分期分层。NUCAI 由六次每两个月进行的 45 分钟咨询组成,是一种以问题为导向的干预措施,旨在帮助患者管理 HNC 及其治疗的身体、心理和社会后果。它由护士主导,与荷兰乌得勒支大学医学中心的常规医疗随访相结合。诊断后 1 年的抑郁症状是主要结局。采用混合效应模型对总样本和基线时抑郁症状水平升高(流行病学研究中心抑郁量表评分≥12;n = 91)的预设亚组患者进行意向治疗分析。
HNC 治疗 1 年后,干预组的抑郁症状水平明显低于对照组,无论是在总样本中还是在抑郁症状水平升高的亚组中。
NUCAI 在诊断后 1 年内降低 HNC 患者的抑郁症状是可行且有效的,特别是在抑郁症状水平升高的患者中。在 NUCAI 可以在日常临床实践中使用之前,需要在未来的研究中进一步验证这些结果。